The document discusses histamine and antihistamines. It defines histamine and explains its biosynthesis from histidine via histidine decarboxylase. It describes the different types of histamine receptors (H1, H2, H3, H4) and their locations. It also classifies and discusses various generations of H1 receptor antagonists (antihistamines), including their structures, mechanisms of action, and uses.
Strategies to synthesize 5 & 6 membered heterocyclic.pptxPrabhjotKaur934413
M. Pharm Pharmaceutical Chemistry ppt on Organic chemistry first semester strategies to synthesize heterocyclic rings A presentation on heterocyclic chemistry
Strategies to synthesize 5 & 6 membered heterocyclic.pptxPrabhjotKaur934413
M. Pharm Pharmaceutical Chemistry ppt on Organic chemistry first semester strategies to synthesize heterocyclic rings A presentation on heterocyclic chemistry
The presentation describes the mechanism action of diuretics with the class of Carbonic anhydrase inhibitors, loop diuretics, thiazides, osmotic and potassium diuretics.
Analog design is usually defined as the modification of a drug molecule or of any bioactive compound in order to prepare a new molecule showing chemical and biological similarity with the original model compound
synthesis of hetero-cyclic drugs which act as anti-malarial drugs where you get all information about synthesis, preparation, properties, uses of drugs.
Proton-pump inhibitors are a group of medications whose main action is a pronounced and long-lasting reduction of stomach acid production. Within the class of medications, there is no clear evidence that one agent works better than another. They are the most potent inhibitors of acid secretion available.
H1-antihistamines are used to treat allergy symptoms. Within this group are two generations called the first generation and second generation antihistamines. H2-antihistamines are used to treat gastrointestinal conditions.
The H2 receptor antagonists are reversible competitive blockers of histamine at the H2 receptors, particularly those in the gastric parietal cells, where they inhibit acid secretion. They are highly selective, do not affect the H1 receptors, and are not anticholinergic agents.
The key difference between H1 and H2 receptors is that the H1 receptor couples with Gq/11 stimulating phospholipase C while the H2 receptor interacts with Gs to activate adenylyl cyclase. Histamine is an organic nitrogenous compound that involves local immune responses.
The presentation describes the mechanism action of diuretics with the class of Carbonic anhydrase inhibitors, loop diuretics, thiazides, osmotic and potassium diuretics.
Analog design is usually defined as the modification of a drug molecule or of any bioactive compound in order to prepare a new molecule showing chemical and biological similarity with the original model compound
synthesis of hetero-cyclic drugs which act as anti-malarial drugs where you get all information about synthesis, preparation, properties, uses of drugs.
Proton-pump inhibitors are a group of medications whose main action is a pronounced and long-lasting reduction of stomach acid production. Within the class of medications, there is no clear evidence that one agent works better than another. They are the most potent inhibitors of acid secretion available.
H1-antihistamines are used to treat allergy symptoms. Within this group are two generations called the first generation and second generation antihistamines. H2-antihistamines are used to treat gastrointestinal conditions.
The H2 receptor antagonists are reversible competitive blockers of histamine at the H2 receptors, particularly those in the gastric parietal cells, where they inhibit acid secretion. They are highly selective, do not affect the H1 receptors, and are not anticholinergic agents.
The key difference between H1 and H2 receptors is that the H1 receptor couples with Gq/11 stimulating phospholipase C while the H2 receptor interacts with Gs to activate adenylyl cyclase. Histamine is an organic nitrogenous compound that involves local immune responses.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
Histamine is a chemical messenger which are synthesized in the mast cell.
Histamine is present in practically all tissues , with significant amounts in the lungs, skin, blood vessels and GI tract.
Generally histamine are found in the animal tissue , venom of insects bacteria and plant.
Histamine a substance that play a major role in many allergic reaction , dilating blood vessel and making the vessel walls abnormally permeable.
Histamine is a signalling molecule ,sending message b/w cells. It tells stomach cells to make stomach acid and it helps our brain
English scientists George Barger and Henry H. Dale first isolated histamine from the plant fungus ergot in 1910 and in 1911 they isolated the substance from animal tissues.
Histamine [2 (imidazole -4-yl) ethylamine] which is biosynthesized by decarboxylation of the basic amino acid histidine ,is found all organ and tissue of the human body.
It is formed by the decarboxylation (the removal of a carboxyl group) of the amino acid histidine.
These are the drugs which diminish or antagonize the action of endogenously released histamine in the body .
Antihistamines are generally antagonist of H1 receptor.
These are used for the treatment of allergy and pruritis
Antagonist of H2 receptor are use to inhibit gastric acid secretion (treatment of peptic ulcer).
The human body contains histaminic receptor and are divided into three different types upon their action
H1- receptor
H2- receptor
H3- receptor
In the year 1933 the first drug Piperoxan invented Bovet & Furnease. This drug can protect the animal from bronchial spasm. The drug is the initiation for the discovery of H1 receptor antagonist.
In the year 1942 , Halpen researched and reported about 24 derivative of ethylene diamine in which Phenbenzamine was found to be most potent and is used the first H1 antagonist used clinically.
H1 antagonists act by competitively inhibiting the effects of histamine at H1 receptor SAR –H1 RECEPTOR ANTAGONISTS 1st Generation Antihistaminic agents PROYLAMINE ANALOGS
It is most potent antihistaminic agents.
The activity is mainly due to geometric isomer in which the pyrrolidino - methyl group is trans to the 2pyridyl group.
E isomer showed more activity then Z isomer.
The histamine H2 receptor antagonist act on H2 receptor in the stomach blood vessel and other sites.
They are competitive antagonist of histamine and are fully reversible
H2 antagonist are group of medicines that reduce the amount of acid produced by the cell in the lining of the stomach are commonly called H2 blocker
These products have been approved for the relief of “heartburn” associated with acid indigestion ,and sour stomach.
Drugs – cimetidine, ranitidine, famotidine.
SAR OF H2 ANTAGONIST
Other Heterocyclic ring present like Cimetidine ( Imidazole) ,ranitidine (furan), famotidine (Thiazole) etc ,that enhance the potency and selectivity of H2 receptor antagonist can be used.
The ring is terminal nitrogen should be separated by four carb
Antihistamines are the drugs that counteract the actions of histamines in the body. Histamine is released by the interaction of antigens with IgE antibodies on the surface of mast cells. Histamine was first identified in 1911 by Barger and Dale. Histamine is a low molecular weight amine synthesized from L-histidine by histidine decarboxylase enzyme and is stored in mast cell and basophill along with heparin protein complex.
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfRAHUL PAL
In the field of formulations, various software tools are commonly used to streamline and optimize the development process. One such software is formulation management software, which helps in creating and managing formulations by allowing scientists to input ingredient quantities, calculate costs, and analyze ingredient interactions. Additionally, simulation software like computational fluid dynamics (CFD) programs are utilized to model and predict how formulations will behave under different conditions, aiding in the design of efficient manufacturing processes. Furthermore, statistical analysis software plays a crucial role in analyzing experimental data and optimizing formulations based on statistical models, ensuring that the final product meets desired specifications. Overall, these software tools enhance productivity, accuracy, and efficiency in the formulation development workflow.
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfRAHUL PAL
Opium cultivation, an ancient practice rooted in regions like the Golden Triangle and Golden Crescent, involves a meticulous process blending nature and human intervention. Picture a serene landscape with gently rolling hills blanketed in lush greenery. Amidst this verdant tapestry stand tall, slender opium poppy plants, their delicate petals shimmering in hues of pink and white. These plants exude an air of mystique, their bulbous seed pods containing the coveted opium latex. Skilled farmers nurture these plants with utmost care, tending to their needs for water, nutrients, and protection from pests. The cultivation cycle begins with sowing the poppy seeds during specific seasons conducive to their growth. As the plants mature, they blossom into exquisite flowers, each harboring the potential for opium production. The farmers deftly slit the seed pods at just the right moment, allowing the milky sap to seep out and gradually solidify into opium. This labor-intensive process demands precision and patience, as any misstep can impact the potency and quality of the opium yield. Despite its allure, opium cultivation is not without controversy and challenges. Legal restrictions, environmental concerns, and the socioeconomic impacts on communities underscore the complex nature of this age-old practice. However, for those entrenched in the art of opium cultivation, it remains a delicate dance between tradition, livelihood, and the ever-evolving dynamics of global demand and supply.
Niosomes are nanosized vesicles composed of nonionic surfactants and cholesterol that form when these compounds are dispersed in an aqueous medium. These lipid-based structures are similar to liposomes but differ in their composition, as niosomes use nonionic surfactants instead of phospholipids. The unique characteristic of niosomes lies in their ability to encapsulate both hydrophilic and hydrophobic drugs within their bilayer membrane. This feature makes them promising candidates for drug delivery systems, as they can protect the encapsulated drug from degradation, prolong its release, and enhance its bioavailability. Additionally, niosomes offer advantages such as biocompatibility, stability, and ease of preparation, making them a versatile platform for targeted drug delivery and other biomedical applications.
Niosome An Non-Ionic Surfactant Vesicles.pptxRAHUL PAL
Niosomes are novel drug delivery systems that have garnered significant interest in the pharmaceutical field. They are essentially vesicles composed of non-ionic surfactants and cholesterol, forming a bilayer structure similar to liposomes. However, unlike liposomes, which are composed of phospholipids, niosomes are formed by self-assembly of non-ionic surfactants in aqueous media. This unique composition offers several advantages such as improved drug solubility, stability, and biocompatibility.
The introduction of niosomes as drug carriers has revolutionized the field of drug delivery due to their ability to encapsulate both hydrophilic and hydrophobic drugs. This versatility allows for targeted and controlled release of therapeutics, enhancing their efficacy while minimizing side effects.
Moreover, the surface of niosomes can be modified to achieve specific targeting of drugs to desired sites within the body, thus enhancing therapeutic outcomes and reducing systemic toxicity.
Overall, niosomes hold great promise in the pharmaceutical industry and continue to be a subject of intense research for their potential applications in various fields including cancer therapy, gene delivery, and vaccine development.
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...RAHUL PAL
Targeted drug delivery systems are employed to administer pharmaceutical medication,
facilitating the precise delivery of drugs to specific diseased areas. Several drug delivery
systems utilise carriers such as antibodies, transdermal patches, biodegradable polymers,
nanoparticles (NPs), liposomes, niosomes, and microspheres. Niosomes, on the other hand,
represent a promising and innovative category of vesicular systems. Niosomes are vesicles
formed by hydrating a combination of nonionic surfactants and cholesterol. These non-ionic
surfactant vesicles serve as carriers for both amphiphilic and lipophilic drugs. In the drug
delivery system using niosomes, the medication is enclosed within a vesicle. Niosomes in
tuberculosis (TB) possess biodegradable and biocompatible properties, are non-immunogenic,
and demonstrate versatility in their structural composition. It’s a serious and potentially deadly
infectious disease caused by a bacteria called Mycobacterium tuberculosis. In the recent
update, WHO still estimates 9.9 million new TB cases in 2022 at the latest. Involvement of
niosomes improves the treatment of TB with much more advanced technology and an advanced
drug nanocarrier with better treatment. The main highlights of this review paper are to
summarise the structure, compositions, preparation methods, and ICH stability guidelines for
the formulation of niosomes and their applications in TB with their several stages of treatment
by niosomal formulations.
Introduction: This study explores the use of Response Surface Methodology (RSM), a statistical optimization technique, to optimize the SR properties of prochlorperazine maleate (PCM) matrix tablets. PCM is a phenothiazine derivative used for treating schizophrenia, nausea, and vomiting. Sustained-release formulations offer extended drug delivery, potentially improving patient compliance and reducing side effects. RSM helps identify optimal combinations of critical formulation factors influencing drug release, such as polymer type and concentration, filler type, and drug/polymer ratio. The study likely involves designing experiments based on chosen RSM designs (e.g., Box-Behnken) with varying factor levels. Formulate SR tablets with different factor combinations. Evaluating the drug release profiles of each tablet formulation. Analyzing data using RSM software to build mathematical models relating factors to drug release and identifying optimal factor combinations that maximize desired release characteristics.
Objective: The ongoing research purpose to improve the advancement of a sustained release tablet containing Phenothiazine derivative PCM loaded matrix. This is achieved by utilizing DoE as a computational method to statistically validate the formulation.
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...RAHUL PAL
This systematic review aims to provide a comprehensive overview of the current status of
mucosal drug delivery systems (MDDS) and explore their future prospects in drug delivery.
MDDS have gained significant attention in recent years due to their potential to enhance drug
absorption, improve therapeutic efficacy, and minimize systemic side effects. This review
critically evaluates the existing literature on MDDS, including various mucosal routes such as
oral, nasal, ocular, pulmonary, and vaginal delivery. Additionally, it discusses the challenges
associated with MDDS, such as formulation development, stability, and regulatory
considerations. Furthermore, this review highlights emerging technologies and innovative
strategies that hold promise for the future of MDDS. Overall, this systematic review provides
valuable insights into the current landscape of MDDS and offers recommendations for future
research and development in this field.
Design of Experiments (DoE) manipulation in the formulation and optimization ...RAHUL PAL
Introduction: In India, the regulatory body for catechu is the Food Safety and Standards Authority of
India (FSSAI). The FSSAI is responsible for regulating the manufacture, sale, and distribution of food in
India, including catechu. The FSSAI has set standards for the purity and quality of catechu, and it also
monitors the market for adulterated catechu. The FDA (The Food and Drug Administration) is
responsible for regulating the safety and efficacy of drugs and dietary supplements in the United States
(US). The FDA has not approved catechu as a drug or dietary supplement, but it does regulate catechu as
a food additive. The FDA has set limits on the amount of catechu that can be added to food
Objective: The primary objective of this research was to involvement of design of experiments (DoE)
manipulation in the formulation and optimization of a traditional Ayurvedic medicine derived from dried
extract of Senegalia catechu enhanced through statistical analysis.
Methodology: The dried extract of Senegalia catechu was collected and identified at the botanical
herbarium garden. Subsequently, it underwent a drying process and was ground into a powder.
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...RAHUL PAL
Objectives: The ongoing research aims to enhance the development of LNH-loaded nanogel by
utilizing DoE as the computational method to statistically validate their formulation.
Methodology: In this research Chitosan used as a natural polymer and Poly (Ethylene glycol)
[PEG] as a penetration or permeation enhancer. The different nanogel of LNH were synthesized
using the Nanoprecipitation and Dispersion method, with variations in the drug-polymer ratio
(1/0.03, 1/0.08, 1/0.12). The process parameters were carefully optimizing for enhance the
efficiency of the synthesis. To achieve this, optimization studies were conducted using 3² FFD,
employing the Design Expert Software Trial version 10.0.7. The total of 13 runs were generated to
ensure comprehensive analysis and evaluation of the procedure. The selected independent
variables included the concentration of Chitosan (R1) and Carbopol 934 (R2). The dependent
variables, on the other hand, were particle size (P1), Polydispersity Index (P2), and % Drug release
(P3), chosen in that order. By employing this optimization technique, one can acquire valuable
information in a manner that is both efficient and cost-effective. This approach facilitates a deeper
comprehension of the relationship between controllable independent variables and the performance
and quality of the Nanogels being produced.
Determination of Partition coefficient of Known and Unknown drug.pdfRAHUL PAL
Partition coefficient, often denoted as P or P_oct, is a measure of how a solute distributes between two immiscible (unmixable) solvents. It is commonly used in chemistry, biochemistry, and pharmacology to understand the distribution of a compound between different phases, such as between a hydrophobic organic solvent and water. In experimental settings, the partition coefficient is determined by measuring the concentrations of the solute in each phase. The values obtained provide insights into the solute's behavior and can guide decisions in various scientific and industrial processes.
A pharmaceutical suspension is a heterogeneous system in which finely divided solid particles are dispersed in a liquid medium. Unlike solutions, where solutes are completely dissolved, suspensions involve particles that are only partially soluble or insoluble in the liquid. These suspensions are commonly used in the pharmaceutical industry to deliver medications that may be poorly soluble or unstable in their pure form. The solid particles, often in the form of powders or crystals, are dispersed throughout the liquid phase, creating a stable mixture through the use of suspending agents or stabilizers. These agents prevent the settling of particles, ensuring uniform distribution and ease of redispersion upon shaking before administration. Pharmaceutical suspensions offer advantages in terms of flexibility in dosing and formulation, enabling the delivery of therapeutic agents in various forms such as oral liquids, injectables, or topical preparations, enhancing patient compliance and therapeutic efficacy. The formulation and stability of pharmaceutical suspensions require careful consideration of factors such as particle size, density, and the choice of stabilizers to maintain a consistent and reliable product.
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptRAHUL PAL
Suppositories and pessaries are both types of medication delivery systems that are designed to be inserted into body orifices for therapeutic purposes. While they serve similar functions, they are used in different parts of the body.
Suppositories:
Usage: Suppositories are typically designed for rectal or vaginal administration.
Composition: They are solid, bullet-shaped or cone-shaped dosage forms that contain medication in a base that melts or dissolves at body temperature.
Rectal Suppositories: Commonly used for medications that need to bypass the digestive system or when a patient cannot take medications orally. They are inserted into the rectum.
Vaginal Suppositories: Often used for localized treatment of gynecological conditions, such as yeast infections or hormonal therapy. They are inserted into the vagina.
Pessaries:
Usage: Pessaries are specifically designed for vaginal administration.
Composition: They are solid, oval-shaped or ring-shaped devices made of various materials such as silicone, rubber, or plastic.
Indications: Pessaries are mainly used to support the uterus, bladder, or rectum in cases of pelvic organ prolapse. However, they can also be used for the controlled release of medication into the vagina for the treatment of local conditions.
Maintenance: Pessaries need to be fitted by a healthcare professional and should be cleaned and reinserted regularly.
Partition Coefficient Determination (Pharmaceutics Practical).pptxRAHUL PAL
Partition coefficients are a fascinating and important concept in many fields, from chemistry and environmental science to medicine and pharmacology. They tell us about how a substance will distribute itself between two immiscible phases, like how a drug might move between your blood and tissues, or how a pollutant might spread through soil and water.
A partition coefficient, denoted as P or log P, describes the ratio of the concentration of a compound in one phase (usually organic) to its concentration in another phase (often water) at equilibrium.
Higher values of P indicate a greater preference for the organic phase, meaning the compound is more lipophilic (fat-loving).
Lower values of P suggest a higher affinity for the aqueous phase, implying the compound is more hydrophilic (water-loving).
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)RAHUL PAL
Declaration of Helsinki: History, introduction, basic principles for all medical research, and additional principles for medical research combined with medical care.
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...RAHUL PAL
The objective of the current studies to enhance the formulation of DS-loaded liposomes through the utilization of Response surface methodology (RSM) and involving the computation approach for their validation.
Investigational outcome represents the perceived responses were in related with the desired values and this represents the relationship of the RSM for optimization of % DR and % EE in DS loaded liposomal preparations.
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...RAHUL PAL
CPCSEA guidelines for laboratory animal facility: Goals, veterinary care, quarantine,
surveillance, diagnosis, treatment and control of disease, personal
hygiene, location of animal facilities to laboratories, anesthesia, euthanasia, physical facilities, environment, animal husbandry, record keeping, SOPs, personnel and
training, transport of lab animals.
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...RAHUL PAL
Medical research in clinical settings is the study of human health and disease in people. It is the primary way that researchers determine if a new form of treatment or prevention, such as a new drug, diet, or medical device, is safe and effective in people.
A clinical trial is designed to learn if a new treatment is more effective or has less harmful side effects than existing treatments.
Clinical trail is basically have 4 phases: Phase I, Phase II, Phase III, Phase IV
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptxRAHUL PAL
Research Methodology and Biostatistics syllabus:
Medical Research: History, values in medical ethics, autonomy, beneficence, non-maleficence, double effect, conflicts between autonomy.
Medical research has a long and varied history. It has evolved from rudimentary practices to sophisticated, evidence-based methodologies. Some key milestones include the development of the scientific method, the use of randomized controlled trials, the discovery of antibiotics, and the mapping of the human genome. Ethical concerns have also played a significant role in shaping the history of medical research, especially in response to various ethical violations, such as the Tuskegee Syphilis Study and the Nuremberg Trials.
Resolving conflicts between these principles often requires careful consideration, ethical analysis, and, in some cases, consultation with ethics committees or boards. The specific course of action may vary based on the individual circumstances and ethical frameworks employed by healthcare professionals and researchers. Ethical guidelines and regulations also play a significant role in addressing and preventing these conflicts in medical research.
Research Article Published: "Optimization and formulation of dox loaded lipos...RAHUL PAL
Doxorubicin (DOX) is a potent anticancer drug, but it is also associated with significant side effects, such as cardiotoxicity. Liposomal encapsulation of DOX can help to reduce these side effects and improve the drug's efficacy.
There are a number of different factors that can affect the optimization and formulation of DOX-loaded liposomes, including:
Lipid composition: The type and ratio of lipids used to form the liposomes can affect their size, stability, and drug encapsulation efficiency. Some commonly used lipids for DOX liposomes include hydrogenated soy phosphatidylcholine (HSPC), cholesterol, and distearoylphosphatidylglycerol (DSPG).
Drug loading method: There are a number of different methods for loading DOX into liposomes. Some common methods include the ammonium sulfate gradient method, the remote loading method, and the ethanol injection method. The choice of loading method can affect the drug encapsulation efficiency and stability of the liposomes.
Liposome size: The size of the liposomes can affect their circulation time in the body and their ability to target specific tissues. Smaller liposomes tend to have a longer circulation time and are better able to penetrate tumors.
Surface modification: Liposomes can be surface-modified with various ligands to improve their targeting and delivery properties. For example, liposomes can be conjugated with antibodies to target specific cancer cells.
The optimization of DOX-loaded liposomes is typically carried out using a quality by design (QbD) approach. QbD is a systematic approach to drug development that focuses on identifying and controlling the critical quality attributes (CQAs) of the drug product. The CQAs of DOX-loaded liposomes may include particle size, drug encapsulation efficiency, stability, and in vitro and in vivo performance.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
MedChem Assignments Histamine, H1, Proton Pump & Cancer (Rahul Pals)
1. The chemical name of Histamine
is “2-(4H-imidazol-5-yl) ethanamine (Histamine)”.
Histamine synthesized in cytoplasmic granules of a its storage cells, mast cells & basophils.
It is formed from naturally occurring amino acids, S-Histidine, via the catalysis of pyridoxal phosphate-
dependent enzymes histidine decarboxylase/ aromatic decarboxylase.
Histamine is a chiral molecule.
HISTAMINE
❑. Question:01 Write the chemical name & structure of Histamine?
❑. Question:02 Explain biosynthesis of Histamine?
NH2
N
HN
H
H
Histamine
HDC
COOH
HN N HN N
H
NH2
NH2
H
H
S-Histidine Histidine
Histidine
Decarboxylase
RAHUL PAL
5TH SEM
B. PHARAM
2. Drugs the block the action of histamine of H1, H2, H4 & H4 receptors.
The development of Antihistamines Began by the discovery of “Piperoxam”.
A. Drugs that inhibits the histamine release.
B. Drugs that inhibits the action of released histamine.
❑ H1 Antagonists (I, II, III generation Antagonists)
❑ H2 Antagonists.
❑ H3 Antagonists.
C. Drugs having dual action.
H1 Antagonists (1st
Generation)
The amine is substituted with the small alkyl group.
Classification: The commonly used antihistamines may be classified on the basis of their chemical
structures:
. Amino Alkyl Ethers: Diphenhydramine, Doxylamine, Clemastine, medrylamine,
Carbinoxmine, Bromodiphenhydramine.
. Ethylenediamine: Tripelenamine, pyrilamine, methapyrilene, thonzalamine, Zolamine.
. Propyl Amine Derivatives: Saturated drugs: pheniramine, chlorpheramine,
Unsaturated Drugs: Pyrrobutamine, triprolidine.
. Phenothiazine Derivatives. Promethazine, Trimeprazine.
. Piperazine Derivative. Cyclazine, chlorcyclines, meclizine.
H1 Antagonists (2nd
Generation)
Laratidine, Estemizole.
H1 Antagonists (3rd
Generation)
Acrivestine.
H2 Antagonists
Cemetidine, famotidine, ranitidine, nizatidine.
H3 Antagonist
Omeprazole, Lansoprazole, Rabeprazole, Pantoprazole.
❑. Question: 03 Classification of Antihistamines?
3. Histamines receptors are belonging to the family of G-Protein Coupled receptors.
These subtypes of histamine receptors:
A. H1.
B. H2.
C. H3.
D. H4.
Receptors H1 H2 H3 H4
Locations Brain, GIT, CVS,
Lymphocytes.
Myocardial cells,
parietal cells.
CNS, Myentric
plexus, gastric
Mucosa.
Spleen, thymus,
T-cells,
eosinophils.
❑. Question: 04 Name the different type of Histamine receptors & their
Distribution?
4. 01. Amino Alkyl Ether: Diphenhydramine, Bromodiphenhydramine, Dimenhydrinate, Doxylamine
succinate, Diphenylpyraline.
02. Ethylenediamine: Mepyramine, Tripelennamine, Thonzylamine, Zolamine.
03. Thiophene Derivatives: Methapyrilene, Methaphenilene, Thenyldiamine, Chlorothen Citrate.
04. Cyclic Basic Chain Analogues:
A. Imidazoline: Antazoline.
B. Piperazine: Cyclizine, Chlorcyclizine, Meclizine, Buclizine.
C. Piperidine: Thenalidine Tartarate.
05. Phenothiazine: Promethazine, Promethazine Teolclate, Trimeprazine, Methdilazine.
06. Second-Generation Non-Sedating Antihistamines: Terfenadine, Astemizole, Loratadine,
Acrivastine.
07. Miscellaneous Agents: Phenindamine, Triprolidine, Chlorpheniramine, Cyproheptadine.
Sedative antihistamines:
N-Dimethylthenamine.HCl & 1-Methyl Piperidine.
Non-Sedative Antihistamine:
Fexofenadine, Citrizine Levocetrazine, loratadine, Desloratadine, Acrivastine.
Ar is Aryl: Phenyl, substituted phenyl, heteroaryl groups such as 2-pyridyl.
Ar1: Second aryl or aryl methyl group.
(CH2) n: Represents a carbon chain, usually ethyl.
NRR1 = Basic, terminal amine functional group.
X = Connecting atom of 0, C & N.
❑. Question:01 Give the classification of H1 Antagonists?
❑. Question:02 Explain SAR of Amino Alkyl Ethers?
H1 ANTAGONISTS
R R1
5. Mepyramine, Tripelennamine, Thonzylamine, Zolamine.
❑. Question:03 Give Chemical Structure of Amino Alkyl Ethers?
❑. Question:04 Give Chemical Structure of Ethylenediamine Derivatives?
Mepyramine Tripelennamine Thonzylamine
Zolamine
6. ANS: Structure Activity Relationship:
➢ Ethylenediamine derivatives are characterized by “Nitrogen” connecting
atom.
➢ Phenbenzamine was first clinically useful member.
➢ Replacement of phenyl moiety of Phenbezamine with a 2-pyridyl system
yielded “tripelennamine”.
➢ Replacements of benzyl group of tripelennamine with a 2-thienulmethyl
group provided methapyrilene.
➢ Replacement of tripelennamine with 2pyridyl group with a pyrimidinyl
moiety yields thonzylamine.
➢ The anticholinergic & antiemetics action of these compounds are low.
#. Mode of Action:
H1 Antagonists act by competitively inhibiting the effects of Histamine at H1
receptor.
H1 receptor blockade results in decreased vascular permeability.
Reduction of pruritus, relaxation of smooth muscle in the respiratory.
GIT.
#. USES: 01. Allergic Reactions.
02. Block the release of histamine.
03. Not effective in humoral & cell mediated allergies.
❑. Question:05 Explain SAR of Ethylenediamine Derivatives?
❑. Question:06 Gives Uses & Mode of Action of H1 Antagonists?
7. The second-generation drugs have little affinity for muscarinic, adrenergic receptors.
The second-Generation have a relative low affinity for central H1 receptor & largely from sedation.
Examples: Terfenadine, Fexofenadine, cetirizine.
“Terfenadine” is a long acting H1 Antagonists.
“Fexofenadine” is a primary oxidation metabolite of “Terfenadine” & does not cross the BBB.
“Cetirizine” highly selective in its interaction with various neuronal binding sites & highly potent as well.
Ar
1 X C C N
Ar’ 3
In the above general structure, Ar is aryl group & Ar’ is aryl methyl group.
In the general structure the X part determines the class of drug to which that belongs i.e. if X = O (amino
alkyl analogue), X = N (Ethylene diamine derivatives).
Some times two aromatic rings are bridges that constitutes the tricycle ring derivatives.
❑. Question:08 Explain SAR of H1 Antagonists?
❑. Question:07 Write the note on Second generation H1 Antagonists?
Terfenadine Fexofenadine
Cetirizine
4
2
8. Most of the H1 Antagonists have ethylene chain, extension of this chain or branching of this chain leads
to reduce the activity of the compounds.
Homologation played to improve the drug like tricyclic anti-depressants, neuroleptics.
Due to the close resemblance of antihistamine structure to the cholinergic blocking agents, most of the
antihistamines show the activity of anti-cholinergic activity.
Diphenhydramine have maximum anti-cholinergic activity & maximum ability to cross the blood brain
barrier & are thus most effective in motion sickness.
#. Uses:
I. It is recommended in various allergic conditions & to a lesser as an antitussive & Parkinsonism
drugs.
II. It is also used OTC sleep air products.
III. Treatment of urticaria, seasonal rhinitis (hey fever) & some dermatoses.
❑. Question:09 Give Synthesis & Use of Diphenhydramine Chloride?
9. Promethazine hydrochloride is a white to faint yellow crystalline powder that Is very soluble in water, in
hot absolute alcohol, in chloroform.
#. USES:
I. Treating allergic illness such as hives, serum disease & hay fever.
II. Enhancing action of analgesics & local anesthetics.
III. Also, treatment of rheumatism with allergic components.
❑. Question:10 Give Synthesis & Use of Promethazine?
10. It is SP2 alkylamine.
It is available as an oral liquid or syrups & is administered every 6 hours.
#. USES:
I. It is used for allergy symptoms, rhinitis.
❑. Question:11 Give synthesis & uses of Triprolidine?
11. “Proton pump inhibitors (PPI) are a group of drugs whose main action is a pronounced & long-lasting
reduction of gastric acid production”.
GIT Problems, Gastritis, Dyspepsia, Peptic Ulcer disease (PUD) & Gastroesophageal reflux disease (GERD)
is the main uses of Proton Pump Inhibitors.
Gastritis Dyspepsia Peptic Ulcer GERD
Gastritis is an
inflammation, irritation
or erosion of the lining
of the stomach.
It can occur suddenly or
gradually.
Dyspepsia is an
uncomfortable feeling in
the upper middle part of
the stomach.
Peptic ulcer disease
refers to painful sores or
ulcers in the lining of
the stomach or first part
of the small intestine,
called the duodenum.
GERD is a digestive
disorder that affects the
lower esophageal
sphincter the ring of
muscle between the
esophagus & stomach.
Examples: Omeprazole, Lansoprazole, Esomeprazole, Pantoprazole & Rabeprazole etc.
Causes & Symptoms
PROTON PUMP INHIBITORS
❑. Question:01 Discuss about Proton Pump Inhibitors?
❑. Question:02 Draw the Chemical Structure of Proton Pump Inhibitors?
Omeprazole
Lansoprazole
Pantoprazole
Rabeprazole
12. Mechanism of blocking Na/K ATPase or Proton Pump
➢ Benzimidazole PPI’s are prodrug that are converted into sulfenamide within the acidic
environment of parietal cells in stomach.
➢ The consumption of food stimulates acid secretion and acid secretion activates PPIs.
➢ Then activated PPI is converted to a sulfenamide in the acidic secretory canaliculi of the parietal
cell.
➢ The sulfenamide interacts covalently with sulfhydryl groups (in cysteine amino acid of the
binding site) in the proton pump to create a disulphide bond between drug and pump and
thereby irreversibly inhibiting its activity.
• Irreversible covalent inhibitors are either substituted 2-
(pyridinemethylsulfinyl)benzimidazoles or a similar structure, pyridylmethyl sulfinyl
pyrido-imidazole, because they mainly inhibits the pump enzyme by covalently binding
to the α-subunit of the H+
,K+
-ATPase.
❑. Question:03 Explain the Mechanism of Action of Proton Pump Inhibitors?
❑. Question:04 Why Proton Pump Inhibitors are irreversible?
13. Mechanism of Acid Secretion: The H+
concentration in parietal cell secretions roughly 3 million-
fold higher than in blood, and Cl-
is secreted against both a concentration and electric gradient. The
parietal cell to secrete acid is dependent on active transport.
Acid secretion through "Proton Pump" located in the canalicular membrane. This ATPase is Mg+
dependent. The current model for explaining acid secretion in above.
• H+
are generated within parietal cell from dissociation of water. The H+
formed in this process
rapidly combine with CO2 to form HCO3
-
, a reaction catalyzed by carbonic anhydrase.
• HCO3
-
transport out from basolateral membrane in exchange for Cl-
. The outflow of bicarbonate
into blood results in a slight elevation of blood pH known as the "alkaline tide". This process
maintains intracellular pH in the parietal cell.
• Cl-
and K+
are transport into lumen of the canaliculus by conductance channels, necessary for
secretion of acid.
• H+
is pump out of cell, into the lumen, in exchange for K+
through the action of the proton pump;
K+
is thus effectively recycled.
• Accumulation of osmotically-active H+
generates an osmotic gradient across the membrane, the
resulting gastric juice is 155 mM HCl and 15 mM KCl with a small amount of NaCl.
❑. Question:05 Explain Secretion of Acid through the Proton Pump?
14. Neoplasm means: Tumour/Cancer.
Cancer is an uncontrolled proliferation express varying degree of fidelity to their precursors.
It can be “benign” or “Malignant”.
Benign: non-cancerous and not an immediate threat to life, even though treatment eventually may be
required for health.
Malignant: tending to worsen and cause death, invasive and metastasis.
01. Cancer involves the development and reproduction of abnormal cell.
02. Cancer cells are usually nonfunctional.
03. Cancer cell growth is not subject to normal body control mechanisms
04. Cancer cells eventually metastasize to other organs via the circulatory and lymphatic systems.
05. Metastasis.
Categorized based on the functions/locations as following:
1. Carcinoma - Skin or in tissues that line or cover internal organs. Ex: Epithelial cells, Glands. 80-
90% reported cancer cases are carcinomas.
2. Sarcoma - Bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue.
3. Leukemia - White blood cells and their precursor cells such as the bone marrow cells, causes
large numbers of abnormal blood cells to be produced and enter the blood.
4. Lymphoma - Cells of the immune system that affects lymphatic system.
5. Myeloma - Beta-cells that produce antibodies- spreads through lymphatic system.
6. Central Nervous System Cancers - Cancers that begin in the tissues of the brain and spinal
cord.
Characterstics
Antineoplastic Drugs
(Cancer)
❑. Question:01 Define Cancer with its Characteristics?
❑. Question:02 Classify Tumors on the basis of their functions/locations?
15. Antineoplastic agents are drugs used for the treatment of cancer.
• The fraction of tumor cells that are in the replicative cycle (“Growth factor”), influence their
susceptibility to most cancer chemotherapeutic agent.
Rapidly dividing cells are generally more sensitive to anticancer drugs, whereas non proliferating
cells [those in G0 phase] usually survive the toxic effect of these drugs.
• Normal cells and tumor cells go through growth cycle. However, normal and neoplastic tissue
may differ only in the number of cells that are in the various stages in the cycle.
Chemotherapeutic agents that are effective only in replicating cells.
01. Phase Specific Agents: These drugs act at particular phase of cell cycle and more effective in
proliferating cells.
❑ G1 – Vincristine
❑ S– Methotrexate, Cytarabine, 6-TG, 6-MP, 5-FU, Daunorubicin, Doxorubicin
❑ G2 – Daunorubicin, Bleomycin
❑ M – Vincristine, Vinblastne, Paclitaxel etc.
02. Phase Non-Specific Agents: Nitrogen Mustards, Cyclphosphamide, Chlorambucil, Carmustine,
Dacarbazine, Busulfan, L-Asparginase, Cisplatin, Procarbazine and Actinomycin D etc.
a) These drugs are specifically effective against proliferating cells but they are not phase specific:
Ex: Fluorouracil, cyclophosphamide, Dactinomycin.
❑. Question:03 Explain the Cell cycle & relation with cancer drugs?
❑. Question:04 Classify Anticancer Agents based on its site of Action?